What does CUSIP 72940R950 represent in this 13F holders report?

CUSIP 72940R950 is the security identifier for 72940R950 - PLURISTEM THERAPEUTICS INC - PUT used to aggregate holder disclosures.

How many institutions held 72940R950 - PLURISTEM THERAPEUTICS INC - PUT in Q2 2020?

No institutional holders were reported for 72940R950 - PLURISTEM THERAPEUTICS INC - PUT in Q2 2020; review adjacent reporting periods for trend context.

PLURISTEM THERAPEUTICS INC - PUT

CUSIP: 72940R950

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class: Equity / PUT
Price per share: $883.76
Number of holders: 0

Quarterly Holders Quick Answers

What is CUSIP 72940R950?
CUSIP 72940R950 identifies 72940R950 - PLURISTEM THERAPEUTICS INC - PUT in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2020
Previous quarter: Q1 2020

Recent filing periods for CUSIP 72940R950:

Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021 Q4 2020

PLURISTEM THERAPEUTICS INC - PUT

Q2 2020 13F Holders as of 30 Jun 2020

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of PLURISTEM THERAPEUTICS INC - PUT as of Q2 2020.